Immunic reported $-22.78M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
BioMarin Pharmaceutical USD 222.32M 76.27M Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
Insmed USD -80.97M 93.7M Sep/2026
Omeros USD -47.96M 7.39M Sep/2023
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 148M 18.7M Sep/2026
Ultragenyx Pharmaceutical USD -61M 94M Jun/2026
United Therapeutics USD 334.2M 20.8M Sep/2026